Answer
Concomitant ceftriaxone treatment with Numeta G13%E Preterm is contraindicated in preterm newborn infants because calcium-ceftriaxone precipitates in the lungs and kidneys have caused fatal reactions in premature newborns.
Sources for this answer
- Numeta G13%E Preterm, emulsion for infusionBaxter Healthcare Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 8Document updated
Sources checked